Ai
Aimmune
Brisbane CAFounded 2011300 employees
Private CapbiotechAcquiredImmunology
Platform: Palforzia
Market Cap
N/A
All Drugs
3
Clinical Trials
7
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Olpaosocimab | AIM-7223 | Approved | 4 | SGLT2 | RSV | ||
| Nidacilimab | AIM-8330 | Preclinical | 1 | JAK1 | LGSDMD | ||
| AIM-9920 | AIM-9920 | Phase 2 | 2 | AuroraA | T2DMM |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (5)